UPDATE: Apellis Pharmaceuticals (APLS) PT Raised to $102 at Goldman Sachs
Tweet Send to a Friend
(Updated - August 9, 2022 3:59 AM EDT)
Goldman Sachs analyst Madhu Kumar raised the price target on Apellis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar raised the price target on Apellis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
